Kristine M. Erlandson, MD

Dr. Erlandson earned an MD from Southern Illinois University School of Medicine. She completed internship at the University of Nebraska Medical Center, an internal medicine residency serving as chief resident at the University of Nebraska Medical Center, and an infectious diseases fellowship at the University of Colorado.

Dr. Erlandson's overall research focuses on the complications of aging in HIV-infection, specifically the mechanisms through which chronic HIV infection leads to early frailty and physical function decline despite otherwise successful antiretroviral therapy. Her current K23 Career Development Award is focused on the relationships of physical function, insulin like growth factor (IGF) -1 pathway, and chronic inflammation, tested through an exercise intervention. She is also exploring motivations and barrier to exercise through qualitative and mixed methods research.

In addition to studies conducted at Colorado, she is active in the AIDS Clinical Trials Group (ACTG) and the Multicenter AIDS Cohort Study (MACS). She directs the frailty and falls assessments of over 1000 study participants at 32 sites for the AIDS Clinical Trials Group HAILO (A5322) study. As a member of the ACTG Inflammation Transformative Science Group, she identifies and develops high-priority studies targeting inflammation and end-organ disease within the ACTG. Her contributions to the field of HIV and aging, particularly the impact on frailty and physical function, are recognized nationally and internationally.